by Annie De Groot | Jun 28, 2019 | Events
7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit Powering Next Generation Targeted Immunotherapies Monday, August 5th – Friday August 9th Westin Boston Waterfront 425 Summer Street Boston, MA 02210 UPDATE: EpiVax Oncology (EO) would like...
by Annie De Groot | Mar 29, 2019 | Events
CIMT 2019 Annual Meeting Tuesday, May 21st – Thursday, May 23rd Rheingoldhalle Congress Center Mainz, Germany Meet members of EpiVax Oncology at the 2019 CIMT meeting, scheduled from May 21-23 at the Rheingoldhalle Congress Center in Mainz, Germany. Every year,...
by Annie De Groot | Mar 28, 2019 | Events
Frontiers in Cancer Immunotherapy Symposium Tuesday, May 14th – Wednesday, May 15th Registration starts at 8:30A.M. on Tuesday The New York Academy of Sciences 7 World Trade Center New York City, New York Meet EpiVax Oncology’s CEO/Co-Founder, Gad Berdugo,...
by Adam | Mar 28, 2019 | News
THIS ORIGINAL ARTICLE WAS PUBLISHED IN PR NEWSWIRE. LINK TO THE ORIGINAL ARTICLE CAN BE FOUND HERE. NEW YORK, March 25, 2019 /PRNewswire/ — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that its abstract has been selected for...
by Sarah Moniz | Jun 13, 2018 | News
NEW YORK CITY AND PROVIDENCE, RI., June 12, 2018 (BUSINESS WIRE) — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced the closing of a $1.2M Bridge Financing. The investors include NextWaveBio, Morningside Venture Investments, Accelerate...
